CytoDyn Announces President Takes Medical Leave of Absence

Antonio Migliarese assumes interim President roleDr. Melissa Palmer appointed interim Chief Medical OfficerDr. Salah Kivlighn joins CytoDyn as clinical and strategic advisor VANCOUVER, Washington,... | June 11, 2023

Related Keywords

Vancouver ,British Columbia ,Canada ,China ,Washington ,United States ,Columbia University ,New York ,India ,Plainview ,America ,Salah Kivlighn ,Cyrus Arman ,Arthurc Guyton ,Gannex Ascletis ,Melissa Palmer ,Thomas Lohmeier ,Antonio Migliarese ,Tanya Urbach ,Advisory Committee On Immunization Practices ,Cytodyn Inc ,Hepatx Corporation ,Kadmon Corporation ,University Of Mississippi Medical Center ,Kite Pharma Inc ,Sanofi Company ,Program Operations For United States Pharmacopeia ,Company Board Of Directors ,Langone Medical Center ,Drug Administration ,Merck Co ,Kivlighn Group ,Astrazeneca ,Exchange Commission ,Iowa State University ,Gilead Sciences ,Hepatology At Mount Sinai School Of Medicine ,Texas Medical Center University Of Houston ,Chief Medical ,Chief Financial Officer ,Chief Medical Officer ,Liver Disease Clinical Development ,Takeda Pharmaceutical ,Medical Center ,Liver Disease ,Mount Sinai School ,Managing Member ,Senior Vice President ,Global Strategic Marketing ,Program Operations ,United States Pharmacopeia ,Latin America ,Commercial Vice President ,Kite Pharma ,Advisory Committee ,Prix Galien Award ,Best Biotechnology Product ,Texas Medical Center ,Baylor College ,Texas Medical School ,Integrated Physiology ,Mississippi Medical Center ,Distributed Studies ,Iowa State ,Board Chair ,